Back to Search
Start Over
A-195 Preliminary Results from an Ongoing Phase 2, Open-Label, Multicenter, Single-Arm Study Assessing an Every-4-Week Dosing Schedule of Mogamulizumab in Patients with Cutaneous T-Cell Lymphoma.
- Source :
-
European Journal of Cancer . 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 09598049
- Volume :
- 211
- Database :
- Academic Search Index
- Journal :
- European Journal of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 180132445
- Full Text :
- https://doi.org/10.1016/j.ejca.2024.114402